title: Targeting the IL-17-T(H)17 pathway.
authors.affiliation: Trinity Partners at 675 Third Avenue, 20th Floor, New York, New York 10017, USA.
authors.forename: Hilary S
authors.initials: HS
authors.lastname: Bartlett
authors.affiliation: Trinity Partners at 675 Third Avenue, 20th Floor, New York, New York 10017, USA.
authors.forename: Ryan P
authors.initials: RP
authors.lastname: Million
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D017326:Clinical Trials, Phase III as Topic / Q000639:trends; D016503:Drug Delivery Systems / Q000639:trends*; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D058504:Th17 Cells / Q000187:drug effects* / Q000378:metabolism
chemical_list: D018501:Antirheumatic Agents; D020381:Interleukin-17